Autolus Therapeutics Announces Publication in Molecular Therapy
April 04, 2023 07:00 ET
|
Autolus Therapeutics plc
- Dual targeting of CD19 and CD22 against B-ALL using a novel high-sensitivity aCD22 CAR - AUTO1/22 may reduce CD19 negative escape in children with B-ALL, and may have broader applications in...
Biopharmaceuticals Contract Manufacturing Market Research 2023-2030 'Reports Insights'
February 27, 2023 07:00 ET
|
REPORTSINSIGHTS CONSULTING PVT LTD
New York, Feb. 27, 2023 (GLOBE NEWSWIRE) -- The Biopharmaceuticals Contract Manufacturing Market is projected to grow at a CAGR of 5.6% from 2023 to 2030, reaching a value of USD 27.6 Billion by...
Biologics Market Size is projected to reach USD 506 Billion by 2030, growing at a CAGR of 4%: Straits Research
June 23, 2022 09:15 ET
|
Straits Research
New York, United States, June 23, 2022 (GLOBE NEWSWIRE) -- The market for biologics is growing steadily because companies are spending a lot of money to improve the places where they make their...
Viral Vector and Plasmid DNA Manufacturing Market To Reach USD 2,493.80 Million By 2026 | Reports And Data
September 30, 2019 11:32 ET
|
Reports and Data
New York, Sept. 30, 2019 (GLOBE NEWSWIRE) -- According to the current analysis of Reports and Data, the global Viral Vector and Plasmid DNA manufacturing market is expected to reach USD 2,493.80...
ProQR Announces Publication on QR-110 for Leber’s Congenital Amaurosis 10 in the Journal Molecular Therapy - Nucleic Acids
August 01, 2018 07:00 ET
|
ProQR Therapeutics N.V.
LEIDEN, the Netherlands, Aug. 01, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the...